Back to News
Market Impact: 0.65

Why Arm Holdings Stock Sank by Over 15% This Week

ARMSPGIUBSMSNFLXNVDANDAQ
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & PositioningTechnology & Innovation
Why Arm Holdings Stock Sank by Over 15% This Week

Arm Holdings (NASDAQ: ARM) shares plummeted over 15% this week following its Q1 FY26 earnings report and disappointing Q2 guidance. While the company reported a 12% year-over-year revenue increase to $1.05 billion (slightly missing consensus) driven by a 25% rise in royalty revenue, non-GAAP net income declined to $374 million. Investor concern primarily stemmed from management's Q2 revenue forecast of $1.01 billion to $1.11 billion, indicating potential sequential stagnation or decline. This outlook prompted several analysts, including UBS and Morgan Stanley, to cut price targets despite maintaining buy recommendations, reflecting dampened sentiment.

Analysis

Arm Holdings (ARM) experienced a significant market repricing, with its stock falling over 15% following the release of its first-quarter fiscal 2026 results. The primary catalyst for the sell-off was not the reported quarter itself, but rather the forward-looking guidance. While the company posted a 12% year-over-year revenue increase to $1.05 billion, this figure narrowly missed the consensus estimate of $1.06 billion. The revenue growth was underpinned by a strong 25% increase in royalty revenue, though this was partially offset by a 1% contraction in the licensing revenue stream. On profitability, non-GAAP net income declined to $374 million from $419 million in the prior-year period, a figure that met analyst expectations. The critical point of concern for investors was management's Q2 forecast, which projects revenue between $1.01 billion and $1.11 billion, indicating a potential sequential decline or, at best, flat performance. This muted outlook prompted analysts at UBS and Morgan Stanley to trim their price targets to $175 and $180 respectively, which, despite their maintained 'buy' ratings, amplified the negative sentiment surrounding near-term growth prospects.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo